Contributed by Tom Harrison| 18 October, 2006 20:01 GMT
It may be possible to completely prevent HIV/AIDS infection within this decade, if all goes well during the clinical test phases of a vaccine under development in Canada.
A South Korean company is financing the work.
Curocom Co. said that it will invest at least $15 million to further development of the vaccine at the University of Western Ontario.
The funding is expected to enable Phase 1 and 2 human clinical trials.
It will cost about $50 million total to complete all the test rounds necessary before the vaccine could be approved for use.
The vaccine has shown promising results in animal studies, according to Dr. Yong Kang, the virologist who developed it.
He expressed cautious optimism about its chances of success with a human population.
Kang believes the vaccine could be ready for use as a therapeutic treatment to clear the virus from infected people in about three years.
He estimates it would take double that time to have a preventative vaccine tested and licensed. |
Home 
*Diseases & Conditions 
